#Medicalmarijuana

A major policy reversal puts Thailand back on a tightly regulated path for cannabis. As of late June, buying cannabis nationwide requires a doctor’s prescription. The aim is to limit use to medical and health contexts, winding back the era of dispensaries and weed cafés that drew tourists from Bangkok to Pattaya.

The shift unsettles a sector that blossomed after decriminalization in 2022. Thailand had become a regional cannabis destination, boosting local tourism and small businesses. Health authorities now argue that liberalization outpaced regulation, pointing to concerns such as rising addiction, underage use, street smoking, and cross-border smuggling.

Thailand, once praised as Asia’s first to decriminalize cannabis, is tightening controls amid controversy and regulatory confusion. New rules require both locals and visitors to hold a medical prescription to purchase cannabis. This marks a sharp turn from the “green rush” that had turned busy streets into cannabis hubs, and aims to restore order to an industry many say grew faster than the system could manage.

The cannabis story in Thailand has drawn wide attention across Asia. The 2025 shift reflects a clash between economic potential, public health, and the country’s image as a regional innovator with deep cultural roots. For Thai readers, the changes touch on health policy, youth behavior, law enforcement, rural livelihoods, and the country’s tourism brand.

A new wave of scientific research challenges some of the most common beliefs about using cannabis to treat health problems such as pain, insomnia, and mental health symptoms like paranoia, highlighting important lessons for Thai readers at a time when medical marijuana access is rapidly expanding in Thailand and across Asia.

The use of cannabis as medicine has surged since Thailand became the first Southeast Asian country to decriminalize cannabis plants in 2022—a move initially aimed to stimulate medical innovation and boost the economy through wellness tourism. But as ever more Thais purchase cannabis products online and at street dispensaries, fresh global research underscores that the effectiveness—and risks—of cannabis for many health problems are far from settled, with strong implications for the Thai public, patients, and caregivers (Washington Post, Medical News Today).

A surge of recent research questions common beliefs about cannabis as a medicine for pain, insomnia, and mental health symptoms such as paranoia. The findings matter for Thai readers as medical cannabis access expands in Thailand and across Asia.

Cannabis has entered mainstream health discussions since Thailand decriminalized cannabis plants in 2022. The move aimed to spur medical innovation and wellness tourism. Yet as more Thais buy cannabis products online and at street dispensaries, new global research shows that evidence on effectiveness and risks is far from settled. This has clear implications for patients, caregivers, and clinicians in Thailand.

New global research paints a nuanced picture of cannabis’ effects on insomnia, chronic pain, and anxiety. Large studies from Australia and the United States show real improvements in quality of life for some patients, but also raise concerns about potential mental health risks such as paranoia, psychosis, and broader psychiatric issues.

For Thai readers, the findings emphasize a careful, evidence-based approach as Thailand continues to navigate its cannabis policy changes. The latest research offers cautious optimism about therapeutic potential while underscoring the need for robust safeguards and education.

Amid rising global interest and legal reforms surrounding cannabis, recent research is painting a complex picture of its true effects on common health problems such as insomnia, chronic pain, and anxiety. A series of large-scale studies from Australia to the United States highlight encouraging long-term improvements in quality of life for patients with stubborn conditions, but also raise serious caution about potential mental health risks such as paranoia, psychosis, and increased risk of psychiatric disorders.

As more older adults in Thailand and around the world turn to cannabis to address chronic pain, insomnia and mental health struggles, a surge of recent research is revealing that age dramatically increases the health risks posed by this once-taboo plant. With the global push towards cannabis legalization and growing acceptance for therapeutic use, experts are warning that older bodies and minds are particularly vulnerable to the potent effects of modern cannabis products—placing Thailand’s rapidly aging population at risk of unanticipated harm (NY Times, Seattle Times).

A growing number of older adults in Thailand and worldwide are turning to cannabis to ease chronic pain, insomnia, and mood issues. New research shows age significantly heightens the health risks of modern cannabis products, prompting serious concern as Thailand’s aging society expands. The trend is fueled by changing laws, shifting attitudes, and aggressive marketing aimed at “wisdom customers,” but health experts warn that older bodies are more vulnerable to the potent effects of today’s cannabis.